CJC-1295 & Ipamorelin Blend (10mg)
$88.00$80.00
The CJC-1295 & Ipamorelin blend is a research compound containing two synthetic peptides that are being investigated for their potential to act as growth hormone secretagogues. CJC-1295 is a growth hormone-releasing hormone (GHRH) agonist, while Ipamorelin is a ghrelin agonist. Both peptides are believed to trigger the anterior pituitary gland to release growth hormone, and when used together, they may exhibit synergistic action.
Product Specifications
Specification | Details |
SKU | P-CJCIPAM-10 |
Purity | >99% |
Form | Lyophilized Powder |
Size | 10 mg (5 mg of each peptide) |
Contents | CJC-1295 NO DAC, Ipamorelin |
Pricing
Free shipping on all orders over $200!
Quantity | Discount | Price (USD) |
Single Unit | N/A | $80.00 |
5 - 8 | 5% | $76.00 |
9+ | 10% | $72.00 |
Chemical Makeup
Peptide | Molecular Formula | Molecular Weight | Other Known Titles |
CJC-1295 | C152H252N44O42 | 3367.9 g/mol | CJC-1295 NO DAC; Mod GRF 1-29 |
Ipamorelin | C38H49N9O5 | 711.8 g/mol | NNC 26-0161 |
Research and Clinical Studies
Half-Life Determination
Research on the individual peptides suggests they have different half-lives, which may lead to a sustained effect when used in a blend.
Ipamorelin has a relatively short half-life of approximately 2 hours, with a single episode of growth hormone release.
CJC-1295 has a much longer half-life, with some studies suggesting it can last up to 8.1 days and lead to a sustained increase in GH production by somatotrophs. It may also upregulate insulin-like growth factor 1 (IGF-1) by an average of 45%.
General Research
In a study on male test subjects, a single introduction of CJC-1295 appeared to cause a 7.5-fold increase in growth hormone pulsatility. Research also suggests that CJC-1295 may interact with the survival and proliferation of somatotroph cells in the anterior pituitary gland, which are responsible for synthesizing growth hormone.
Ipamorelin, on the other hand, is believed to act on the anterior pituitary via a different pathway involving G-proteins, which can lead to the release of calcium ions and activate other signaling molecules that ultimately promote growth hormone release.
Nitrogen Balance
The blend's potential to increase growth hormone production may lead to a positive nitrogen balance, which is associated with an increase in lean mass. In a study on Ipamorelin, researchers found that it appeared to lead to a 20% decline in urea-N production and reinstated nitrogen equilibrium, suggesting it may enhance nitrogen values in organs.
Disclaimer: The CJC-1295 & Ipamorelin peptide blend is available for research and laboratory purposes only.
